Point-of-care ultrasonography in the allergy and immunology clinic
- PMID: 30776445
- DOI: 10.1016/j.anai.2019.02.010
Point-of-care ultrasonography in the allergy and immunology clinic
Abstract
Objective: To summarize evidence supporting the use of point-of-care ultrasonography as a clinical tool for allergists and immunologists.
Data sources: Cochrane Library, Medline, EMBASE, and Scopus databases were searched for articles published before December 18, 2018.
Study selections: We included any retrospective or prospective study that evaluated ultrasonography in allergy and immunology and epinephrine autoinjector (EAI) needle length.
Results: The standard EAI needle length may be inadequate for intramuscular delivery of epinephrine, particularly for women, at risk of anaphylaxis. In patients who weigh less than 15 kg, the lengths of commercially available EAIs may be too long, risking inadvertent intraosseous injection and resultant complications. Ultrasonography can be routinely used in the allergy clinic to guide needle length and angle for subcutaneous allergen immunotherapy injections to minimize systemic adverse effects.
Conclusion: Point-of-care ultrasonography can be a useful tool to enhance patient care and safety in an allergy clinic. Ideally, all patients prescribed EAIs should have ultrasonographic measurement of the skin to muscle distance and skin to bone distance to assist in identifying patients at risk of subcutaneous or intraosseous injection in anaphylaxis and those at risk of intramuscular injection during subcutaneous allergen immunotherapy injections.
Copyright © 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers.Ann Allergy Asthma Immunol. 2017 Jun;118(6):719-725.e1. doi: 10.1016/j.anai.2017.03.017. Epub 2017 May 6. Ann Allergy Asthma Immunol. 2017. PMID: 28483294
-
Frequencies and predictors of subcutaneous and intraosseous injection with 4 epinephrine autoinjector devices.Ann Allergy Asthma Immunol. 2024 Aug;133(2):194-202.e5. doi: 10.1016/j.anai.2024.05.002. Epub 2024 May 11. Ann Allergy Asthma Immunol. 2024. PMID: 38740133
-
Epinephrine auto-injector needle lengths: Can both subcutaneous and periosteal/intraosseous injection be avoided?Ann Allergy Asthma Immunol. 2018 Jun;120(6):648-653.e1. doi: 10.1016/j.anai.2018.02.028. Epub 2018 Feb 27. Ann Allergy Asthma Immunol. 2018. PMID: 29499370
-
Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.CMAJ. 1995 May 1;152(9):1413-9. CMAJ. 1995. PMID: 7728690 Free PMC article. Review.
-
[WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].Wien Med Wochenschr. 1999;149(14-15):410-4. Wien Med Wochenschr. 1999. PMID: 10584284 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical